Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 2.89% is 96% above its 5-year average of 1.48%, near the low end of its 5-year range (-54.08%–326.02%).
As of the fiscal period ended Tuesday, June 30, 2026. 78.26% below its 12-month average of 13.28%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 2.89%.
RETURN ON EQUITY (ROE)
2.89%
RETURN ON EQUITY (ROE) AVG TTM
13.28%
RETURN ON EQUITY (ROE) AVG 3Y
23.46%
RETURN ON EQUITY (ROE) AVG 5Y
1.48%
RETURN ON EQUITY (ROE) AVG 10Y
-8.46%
RETURN ON EQUITY (ROE) AVG 15Y
-12.93%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-78.26%
CURRENT VS 3Y AVG
-87.69%
CURRENT VS 5Y AVG
+95.70%
CURRENT VS 10Y AVG
+134.15%
CURRENT VS 15Y AVG
+122.34%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-39.44%
median of 550 covered companies
CURRENT VS SECTOR MEDIAN
+107.32%
vs the sector median at left
MiMedx Group, Inc.
Market Cap
$665.40M
Return on Equity (ROE)
2.89%
TTM Avg
13.28%
3Y Avg
23.46%
5Y Avg
1.48%
Market Cap
$666.36M
Return on Equity (ROE)
-43.95%
TTM Avg
-29.61%
3Y Avg
-34.61%
5Y Avg
-30.48%
Market Cap
$666.95M
Return on Equity (ROE)
-75.79%
TTM Avg
-55.51%
3Y Avg
-59.06%
5Y Avg
-60.41%
Market Cap
$676.72M
Return on Equity (ROE)
-108.93%
TTM Avg
-72.41%
3Y Avg
-64.95%
5Y Avg
-55.74%
Market Cap
$643.45M
Return on Equity (ROE)
-17.01%
TTM Avg
-22.91%
3Y Avg
-17.12%
5Y Avg
-14.58%
Market Cap
$692.29M
Return on Equity (ROE)
-41.20%
TTM Avg
50554.28%
3Y Avg
25132.94%
5Y Avg
16622.35%
Market Cap
$636.48M
Return on Equity (ROE)
-24.06%
TTM Avg
-36.09%
3Y Avg
-34.99%
5Y Avg
-44.03%
Market Cap
$635.69M
Return on Equity (ROE)
-41.56%
TTM Avg
-67.38%
3Y Avg
-49.66%
5Y Avg
-56.07%
Market Cap
$704.02M
Return on Equity (ROE)
-113.05%
TTM Avg
-95.98%
3Y Avg
-72.88%
5Y Avg
-73.85%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiMedx Group, Inc. (MDXG) | $665.40M | 2.89% | 13.28% | 23.46% | 1.48% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $666.36M | -43.95% | -29.61% | -34.61% | -30.48% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | -75.79% | -55.51% | -59.06% | -60.41% |
| Annexon, Inc. (ANNX)vs › | $676.72M | -108.93% | -72.41% | -64.95% | -55.74% |
| OmniAb, Inc. (OABI)vs › | $643.45M | -17.01% | -22.91% | -17.12% | -14.58% |
| Anteris Technologies Global Corp. (AVR)vs › | $692.29M | -41.20% | 50554.28% | 25132.94% | 16622.35% |
| Climb Bio, Inc. (CLYM)vs › | $636.48M | -24.06% | -36.09% | -34.99% | -44.03% |
| Aura Biosciences, Inc. (AURA)vs › | $635.69M | -41.56% | -67.38% | -49.66% | -56.07% |
| Faeth Therapeutics, Inc. (FTH)vs › | $704.02M | -113.05% | -95.98% | -72.88% | -73.85% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $707.95M | -47.51% | -32.80% | -39.18% | -31.37% |
ROE
2.9%
ROA
2.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 2.89% |
| 2026-03-31 | 12.64% |
| 2025-12-31 | 18.94% |
| 2025-09-30 | 17.09% |
| 2025-06-30 | 14.85% |
| 2025-03-31 | 19.82% |
| 2024-12-31 | 21.97% |
| 2024-09-30 | 48.87% |
| 2024-06-30 | 52.90% |
| 2024-03-31 | 46.54% |
| 2023-12-31 | 40.80% |
| 2023-09-30 | 326.02% |
| 2023-06-30 | -15.81% |
| 2023-03-31 | -33.12% |
| 2022-12-31 | -40.53% |
| 2022-09-30 | -37.78% |
| 2022-06-30 | -27.23% |
| 2022-03-31 | -14.57% |
| 2021-12-31 | -11.11% |
| 2021-09-30 | -33.55% |
| 2021-06-30 | -54.08% |
| 2021-03-31 | -62.93% |
| 2020-12-31 | -53.91% |
| 2020-09-30 | -38.64% |
| 2020-06-30 | -36.68% |
| 2020-03-31 | -56.46% |
| 2019-12-31 | -74.36% |
| 2019-09-30 | -137.28% |
| 2019-06-30 | -270.96% |
| 2019-03-31 | -124.82% |
| 2018-12-31 | -60.37% |
| 2017-12-31 | 87.71% |
| 2017-09-30 | 24.80% |
| 2017-06-30 | 14.39% |
| 2017-03-31 | 11.71% |
| 2016-12-31 | 9.00% |
| 2016-09-30 | 16.12% |
| 2016-06-30 | 19.00% |
| 2016-03-31 | 23.25% |
| 2015-12-31 | 27.27% |
| 2015-09-30 | 19.80% |
| 2015-06-30 | 18.29% |
| 2015-03-31 | 13.00% |
| 2014-12-31 | 6.96% |
| 2014-09-30 | 1.18% |
| 2014-06-30 | -4.09% |
| 2014-03-31 | -4.48% |
| 2013-12-31 | -5.59% |
| 2013-09-30 | -12.07% |
| 2013-06-30 | -24.94% |
| 2013-03-31 | -25.92% |
| 2012-12-31 | -38.30% |
| 2012-09-30 | -45.01% |
| 2012-06-30 | -39.45% |
| 2012-03-31 | -63.54% |
| 2011-12-31 | -85.69% |
| 2011-09-30 | -87.27% |
| 2011-06-30 | -88.45% |
| 2011-03-31 | -93.87% |
| 2010-12-31 | -187.19% |
| 2010-09-30 | -152.42% |
| 2010-06-30 | -125.54% |
| 2010-03-31 | -124.53% |
| 2009-09-30 | -447.34% |
| 2009-06-30 | -734.10% |
| 2009-03-31 | -552.78% |
